Evidence map›Paper›PMID 32979398›Full record

ReviewFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2020

SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.

Aristides Tsatsakis, Daniela Calina, Luca Falzone, Dimitrios Petrakis, Radu Mitrut, Vasileios Siokas, Manuela Pennisi, Giuseppe Lanza, Massimo Libra, Sotirios G Doukas and 10 more

Open access · greenAbstract readReview
In one paragraph

Review in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. COVID-19 and Mental Health: A "Pandemic Within a Pandemic".Advances in experimental medicine and biology · 2024
    Review
  11. Effect of Aviptadil, a Novel Therapy, on Clinical Outcomes of Patients with Viral-related Severe ARDS: A Retrospective Observational Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.Acta biochimica et biophysica Sinica · 2022
    Review
  18. Article
  19. Review
  20. Acute limb ischaemia: not an uncommon complication of COVID-19 infection.Annals of the Royal College of Surgeons of England · 2022
    Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 6 countries.

Aristides TsatsakisDepartment of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece; I.M. Sechenov First Moscow State Medical University (Sechenov University), 119146, Moscow, Russia. Electronic address: tsatsaka@uoc.gr.
Daniela CalinaDepartment of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. Electronic address: calinadaniela@gmail.com.
Luca FalzoneEpidemiology Unit, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", 80131, Naples, Italy. Electronic address: l.falzone@istitutotumori.na.it.
Dimitrios PetrakisDepartment of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece. Electronic address: dimitriospetrakis@hotmail.com.
Radu MitrutDepartment of Cardiology, University and Emergency Hospital, 050098, Bucharest, Romania. Electronic address: radumitrut@yahoo.co.uk.
Vasileios SiokasDepartment of Neurology, University of Thessaly, University Hospital of Larissa, 41221, Larissa, Greece. Electronic address: bill_s1983@hotmail.com.
Manuela PennisiDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy. Electronic address: manuela.pennisi@unict.it.
Giuseppe LanzaDepartment of Surgery and Medical-Surgical Specialties, University of Catania, 95123, Catania, Italy; Department of Neurology IC, Oasi Research Institute-IRCCS, 94018, Troina, Italy. Electronic address: giuseppe.lanza1@unict.it.
Massimo LibraDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy; Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123, Catania, Italy. Electronic address: m.libra@unict.it.
Sotirios G DoukasDepartment of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece; Department of Internal Medicine, Saint Peter's University Hospital, 254 Easton Ave, New Brunswick, NJ, 08901, USA. Electronic address: sotirios.doukas.mail@gmail.com.
Panagiotis G DoukasUniversity of Pavol Josef Safarik University, Faculty of Medicine, Kosice, Slovakia. Electronic address: panagiotis.doukas.mail@gmail.com.
Leena KavaliDepartment of Internal Medicine, Saint Peter's University Hospital, 254 Easton Ave, New Brunswick, NJ, 08901, USA. Electronic address: leena.kavali@gmail.com.
Amar BukhariDepartment of Medicine, Division of Pulmonary and Critical Care 240 Easton Ave, Adult Ambulatory at Cares Building 4th Floor, New Brunswick, NJ, 08901, USA. Electronic address: ABukhari@saintpetersuh.com.
Chiranjeevi GadiparthiDivision of Gastroenterology, Hepatology and Clinical Nutrition, Saint Peter's University Hospital, New Brunswick, NJ, USA. Electronic address: cgadiparthi@saintpetersuh.com.
Dimitra P VageliDepartment of Surgery, The Yale Larynx Laboratory, New Haven, CT, 06510, USA. Electronic address: dimitra.vangeli@yale.edu.
Diamantis P KofteridisDepartment of Internal Medicine, University Hospital of Heraklion, 71110, Heraklion, Crete, Greece. Electronic address: kofteridisd@hotmail.com.
Demetrios A SpandidosLaboratory of Clinical Virology, Medical School, University of Crete, Heraklion, 71003, Greece. Electronic address: spandidos@spandidos.gr.
Monica M B PaolielloDepartment of Molecular Pharmacology, Albert Eisntein College of Medicine, 1300 Morris Park Avenue Bronx, NY, 10461, USA. Electronic address: monibas2@gmail.com.
Michael AschnerI.M. Sechenov First Moscow State Medical University (Sechenov University), 119146, Moscow, Russia; Department of Molecular Pharmacology, Albert Eisntein College of Medicine, 1300 Morris Park Avenue Bronx, NY, 10461, USA. Electronic address: michael.aschner@einsteinmed.org.
Anca Oana DoceaDepartment of Toxicology, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. Electronic address: daoana00@gmail.com.
Saint Peter's University Hospital · USUniversity of Catania · ITUniversity of Crete · GRAlbert Einstein College of Medicine · USUniversity of Medicine and Pharmacy of Craiova · ROClinical Emergency Hospital Bucharest · ROIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITPulmonary and Critical Care Associates · USUniversity Hospital of Heraklion · GRUniversity of Pavol Jozef Šafárik · SKUniversity of Thessaly · GRYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to severe acute respiratory distress. The severity of the illness can also extend from mild disease to life-threatening acute respiratory distress syndrome (ARDS). SARS-CoV-2 infection can also affect the gastrointestinal tract, liver and pancreatic functions, leading to gastrointestinal symptoms. Moreover, SARS-CoV-2 can cause central and peripheral neurological manifestations, affect the cardiovascular system and promote renal dysfunction. Epidemiological data have indicated that cancer patients are at a higher risk of contracting the SARS-CoV-2 virus. Considering the multitude of clinical symptoms of COVID-19, the objective of the present review was to summarize their pathophysiology in previously healthy patients, as well as in those with comorbidities. The present review summarizes the current, though admittedly fluid knowledge on the pathophysiology and symptoms of COVID-19 infection. Although unclear issues still remain, the present study contributes to a more complete understanding of the disease, and may drive the direction of new research. The recognition of the severity of the clinical symptoms of COVID-19 is crucial for the specific therapeutic management of affected patients.

Indexed as

Cardiovascular DiseasesComorbidityCOVID-19COVID-19 Drug TreatmentDigestive System DiseasesFemaleHumansKidney DiseasesLung DiseasesMaleNeoplasmsNervous System DiseasesPandemicsSARS-CoV-2CancerCardiovascular systemClinical signsCOVID-19 pandemicGastrointestinal systemNeurological systemPulmonary systemSARS-C0V-2

Identifiers

PMID32979398
PMCPMC7833750
OpenAlexW3088522588

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.